DXCM stock forecast
Our latest prediction for DexCom, Inc.'s stock price was made on the Sept. 10, 2020 when the stock price was at 390.02$.
In the short term (2weeks), DXCM's stock price should underperform the market by -0.73%. During that period the price should oscillate between -7.59% and +6.95%.
In the medium term (3months), DXCM's stock price should underperform the market by -1.90%. During that period the price should oscillate between -25.88% and +16.27%.Get email alerts
Create a solid portfolio with DXCM
About DexCom, Inc.
DexCom, Inc. is a medical device manufacturing company. The firm engages in the design, development and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G4 PLATINUM System, DexCom G5 Mobil, DexCom Share and Mobile apps. The company was founded by John F. Burd on May 1, 1999 and is headquartered in San Diego, CA.
At the moment the company generates 1716M USD in revenues.
On its last earning announcement, the company reported a profit of 2.20$ per share.
The book value per share is 5.46$
Three months stock forecastSept. 10, 2020
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|